300
Participants
Start Date
April 1, 2024
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2028
PD-1 monoclonal antibody and lenvatinib
Patient receives first adjuvant PD-1 monoclonal antibody 2-4 weeks postoperatively, 200 mg IV, every 21 days for a total of 9 cycles; lenvatinib is initiated orally 2-4 weeks postoperatively for 6 months.
PD-1 monoclonal antibody
Patient receives first adjuvant PD-1 monoclonal antibody 2-4 weeks postoperatively, 200mg IV over 21 days for 9 cycles.
RECRUITING
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China, Wuhan
Chen Xiaoping
OTHER